U.S.

PoNS device made available to US veterans through new collaboration

Helius Medical Technologies is collaborating with Lovell Government Services to make its PoNS deviceĀ ā€” designed to improve walking ability in people withĀ multiple sclerosis (MS) ā€” available to U.S. veterans and MS patients in other federal healthcare systems. The PoNS device, officially named the Portable Neuromodulation Stimulator, is…

Use of oral DMTs grew substantially since their launch: US study

Since their launch in the 2010s, the use of oral disease-modifying treatments (DMTs) for multiple sclerosis (MS) has increased substantially, while injectable DMTs have become less popular, according to a study based on U.S. commercial health insurance data. ā€œWhile two injectable therapies known as platform injectables, were once the…

Young MS Patients in the US More Likely to Be Overweight and Suffer More Relapses Than Peers Elsewhere, Study Finds

Scientists at the Pediatric MS Center at NYU Langone, New York, reported that U.S. adolescents withĀ multiple sclerosis (MS) receivingĀ interferon-beta 1a therapyĀ had a higher body mass index (BMI), more relapses, and were managed differently compared to patients of similar age in seven other countries. The study, “Subcutaneous…